DNAnexus and Oracle Collaborate to Integrate Genomic Data into Clinical Settings

DNAnexus and Oracle have partnered to integrate genomic data into Oracle Health's clinical applications, aiming to bring precision medicine capabilities to the point of care. The collaboration is expected to power continuous examination of clinical interpretations of genomics results, helping doctors better understand adaptations that may impact a patient's health or require adjustments to their treatment plan.

DNAnexus and Oracle have announced a strategic partnership to integrate genomic data into Oracle Health's clinical applications, aiming to bring precision medicine capabilities to the point of care. The collaboration is expected to power continuous examination of clinical interpretations of genomics results, helping doctors better understand adaptations that may impact a patient's health or require adjustments to their treatment plan.

The partnership, executed as part of a non-binding agreement, will combine DNAnexus' advanced genomics data infrastructure with Oracle Health's EHR (Electronic Health Record). This integration is designed to enhance the clinical setting by providing healthcare professionals with tools to deliver exceptional, personalized patient care.

Thomas Laur, CEO of DNAnexus, commented, "This collaboration is about enabling a new era of data-driven healthcare. By aligning our technology with Oracle's EHR, we can help customers fully harness the power of molecular data, bringing critical context and insights to the point of care."

Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences, added, "Arming physicians with insights based on the latest interpretations of genomic data will help improve patient care and advance our understanding of the relationship between care paths and care outcomes. Our collaboration with DNAnexus is a key step toward building a learning health system that adapts in real time to the needs of patients, clinicians, and researchers around the world."

The integration is expected to be executed as part of a non-binding agreement and will focus on powering continuous examination of clinical interpretations of genomics results. This will help doctors better understand adaptations that may impact a patient's health or require adjustments to their treatment plan.

DNAnexus and Oracle are scheduled to present more details on their collaboration at the Oracle Health and Life Sciences Summit, taking place on September 11, 2025. The summit will feature keynote panel discussions and sessions focused on the integration of genomics data into clinical applications.

DNAnexus, the enterprise platform for precision health data, is on a mission to accelerate the development, approval, and delivery of personalized treatments. The company's flexible ecosystem makes omics and real-world data accessible, actionable, and secure while unlocking insights that improve patient lives.

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. The company is committed to advancing precision medicine and improving patient outcomes through innovative technology solutions.

For more information about DNAnexus, visit [www.dnanexus.com](http://www.dnanexus.com) or follow @DNAnexus on social media. For more information about Oracle, visit [www.oracle.com](http://www.oracle.com).

Trademarks: Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

Media Contacts:
- Meredith Schwenk, DNAnexus: mschwenk@dnanexus.com
- Judi Palmer, Oracle PR: judi.palmer@oracle.com

Source: DNAnexus [^NUMBER:1]